Cargando…

Trpm4 Gene Invalidation Leads to Cardiac Hypertrophy and Electrophysiological Alterations

RATIONALE: TRPM4 is a non-selective Ca(2+)-activated cation channel expressed in the heart, particularly in the atria or conduction tissue. Mutations in the Trpm4 gene were recently associated with several human conduction disorders such as Brugada syndrome. TRPM4 channel has also been implicated at...

Descripción completa

Detalles Bibliográficos
Autores principales: Demion, Marie, Thireau, Jérôme, Gueffier, Mélanie, Finan, Amanda, Khoueiry, Ziad, Cassan, Cécile, Serafini, Nicolas, Aimond, Franck, Granier, Mathieu, Pasquié, Jean-Luc, Launay, Pierre, Richard, Sylvain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274076/
https://www.ncbi.nlm.nih.gov/pubmed/25531103
http://dx.doi.org/10.1371/journal.pone.0115256
_version_ 1782349932367183872
author Demion, Marie
Thireau, Jérôme
Gueffier, Mélanie
Finan, Amanda
Khoueiry, Ziad
Cassan, Cécile
Serafini, Nicolas
Aimond, Franck
Granier, Mathieu
Pasquié, Jean-Luc
Launay, Pierre
Richard, Sylvain
author_facet Demion, Marie
Thireau, Jérôme
Gueffier, Mélanie
Finan, Amanda
Khoueiry, Ziad
Cassan, Cécile
Serafini, Nicolas
Aimond, Franck
Granier, Mathieu
Pasquié, Jean-Luc
Launay, Pierre
Richard, Sylvain
author_sort Demion, Marie
collection PubMed
description RATIONALE: TRPM4 is a non-selective Ca(2+)-activated cation channel expressed in the heart, particularly in the atria or conduction tissue. Mutations in the Trpm4 gene were recently associated with several human conduction disorders such as Brugada syndrome. TRPM4 channel has also been implicated at the ventricular level, in inotropism or in arrhythmia genesis due to stresses such as ß-adrenergic stimulation, ischemia-reperfusion, and hypoxia re-oxygenation. However, the physiological role of the TRPM4 channel in the healthy heart remains unclear. OBJECTIVES: We aimed to investigate the role of the TRPM4 channel on whole cardiac function with a Trpm4 gene knock-out mouse (Trpm4 (-/-)) model. METHODS AND RESULTS: Morpho-functional analysis revealed left ventricular (LV) eccentric hypertrophy in Trpm4 (-/-) mice, with an increase in both wall thickness and chamber size in the adult mouse (aged 32 weeks) when compared to Trpm4(+/+) littermate controls. Immunofluorescence on frozen heart cryosections and qPCR analysis showed no fibrosis or cellular hypertrophy. Instead, cardiomyocytes in Trpm4(-/-) mice were smaller than Trpm4(+/+)with a higher density. Immunofluorescent labeling for phospho-histone H3, a mitosis marker, showed that the number of mitotic myocytes was increased 3-fold in the Trpm4(-/-)neonatal stage, suggesting hyperplasia. Adult Trpm4 (-/-) mice presented multilevel conduction blocks, as attested by PR and QRS lengthening in surface ECGs and confirmed by intracardiac exploration. Trpm4(-/-)mice also exhibited Luciani-Wenckebach atrioventricular blocks, which were reduced following atropine infusion, suggesting paroxysmal parasympathetic overdrive. In addition, Trpm4 (-/-) mice exhibited shorter action potentials in atrial cells. This shortening was unrelated to modifications of the voltage-gated Ca(2+) or K(+) currents involved in the repolarizing phase. CONCLUSIONS: TRPM4 has pleiotropic roles in the heart, including the regulation of conduction and cellular electrical activity which impact heart development.
format Online
Article
Text
id pubmed-4274076
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-42740762014-12-31 Trpm4 Gene Invalidation Leads to Cardiac Hypertrophy and Electrophysiological Alterations Demion, Marie Thireau, Jérôme Gueffier, Mélanie Finan, Amanda Khoueiry, Ziad Cassan, Cécile Serafini, Nicolas Aimond, Franck Granier, Mathieu Pasquié, Jean-Luc Launay, Pierre Richard, Sylvain PLoS One Research Article RATIONALE: TRPM4 is a non-selective Ca(2+)-activated cation channel expressed in the heart, particularly in the atria or conduction tissue. Mutations in the Trpm4 gene were recently associated with several human conduction disorders such as Brugada syndrome. TRPM4 channel has also been implicated at the ventricular level, in inotropism or in arrhythmia genesis due to stresses such as ß-adrenergic stimulation, ischemia-reperfusion, and hypoxia re-oxygenation. However, the physiological role of the TRPM4 channel in the healthy heart remains unclear. OBJECTIVES: We aimed to investigate the role of the TRPM4 channel on whole cardiac function with a Trpm4 gene knock-out mouse (Trpm4 (-/-)) model. METHODS AND RESULTS: Morpho-functional analysis revealed left ventricular (LV) eccentric hypertrophy in Trpm4 (-/-) mice, with an increase in both wall thickness and chamber size in the adult mouse (aged 32 weeks) when compared to Trpm4(+/+) littermate controls. Immunofluorescence on frozen heart cryosections and qPCR analysis showed no fibrosis or cellular hypertrophy. Instead, cardiomyocytes in Trpm4(-/-) mice were smaller than Trpm4(+/+)with a higher density. Immunofluorescent labeling for phospho-histone H3, a mitosis marker, showed that the number of mitotic myocytes was increased 3-fold in the Trpm4(-/-)neonatal stage, suggesting hyperplasia. Adult Trpm4 (-/-) mice presented multilevel conduction blocks, as attested by PR and QRS lengthening in surface ECGs and confirmed by intracardiac exploration. Trpm4(-/-)mice also exhibited Luciani-Wenckebach atrioventricular blocks, which were reduced following atropine infusion, suggesting paroxysmal parasympathetic overdrive. In addition, Trpm4 (-/-) mice exhibited shorter action potentials in atrial cells. This shortening was unrelated to modifications of the voltage-gated Ca(2+) or K(+) currents involved in the repolarizing phase. CONCLUSIONS: TRPM4 has pleiotropic roles in the heart, including the regulation of conduction and cellular electrical activity which impact heart development. Public Library of Science 2014-12-22 /pmc/articles/PMC4274076/ /pubmed/25531103 http://dx.doi.org/10.1371/journal.pone.0115256 Text en © 2014 Demion et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Demion, Marie
Thireau, Jérôme
Gueffier, Mélanie
Finan, Amanda
Khoueiry, Ziad
Cassan, Cécile
Serafini, Nicolas
Aimond, Franck
Granier, Mathieu
Pasquié, Jean-Luc
Launay, Pierre
Richard, Sylvain
Trpm4 Gene Invalidation Leads to Cardiac Hypertrophy and Electrophysiological Alterations
title Trpm4 Gene Invalidation Leads to Cardiac Hypertrophy and Electrophysiological Alterations
title_full Trpm4 Gene Invalidation Leads to Cardiac Hypertrophy and Electrophysiological Alterations
title_fullStr Trpm4 Gene Invalidation Leads to Cardiac Hypertrophy and Electrophysiological Alterations
title_full_unstemmed Trpm4 Gene Invalidation Leads to Cardiac Hypertrophy and Electrophysiological Alterations
title_short Trpm4 Gene Invalidation Leads to Cardiac Hypertrophy and Electrophysiological Alterations
title_sort trpm4 gene invalidation leads to cardiac hypertrophy and electrophysiological alterations
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274076/
https://www.ncbi.nlm.nih.gov/pubmed/25531103
http://dx.doi.org/10.1371/journal.pone.0115256
work_keys_str_mv AT demionmarie trpm4geneinvalidationleadstocardiachypertrophyandelectrophysiologicalalterations
AT thireaujerome trpm4geneinvalidationleadstocardiachypertrophyandelectrophysiologicalalterations
AT gueffiermelanie trpm4geneinvalidationleadstocardiachypertrophyandelectrophysiologicalalterations
AT finanamanda trpm4geneinvalidationleadstocardiachypertrophyandelectrophysiologicalalterations
AT khoueiryziad trpm4geneinvalidationleadstocardiachypertrophyandelectrophysiologicalalterations
AT cassancecile trpm4geneinvalidationleadstocardiachypertrophyandelectrophysiologicalalterations
AT serafininicolas trpm4geneinvalidationleadstocardiachypertrophyandelectrophysiologicalalterations
AT aimondfranck trpm4geneinvalidationleadstocardiachypertrophyandelectrophysiologicalalterations
AT graniermathieu trpm4geneinvalidationleadstocardiachypertrophyandelectrophysiologicalalterations
AT pasquiejeanluc trpm4geneinvalidationleadstocardiachypertrophyandelectrophysiologicalalterations
AT launaypierre trpm4geneinvalidationleadstocardiachypertrophyandelectrophysiologicalalterations
AT richardsylvain trpm4geneinvalidationleadstocardiachypertrophyandelectrophysiologicalalterations